Skip to main content
. 2021 Feb 16;11(2):e042391. doi: 10.1136/bmjopen-2020-042391

Figure 1.

Figure 1

Illustration of study design and timeline for (A) study population and GPs, (B) definition of control period (12 months of stable GP activity on own patient list), exposure time periods during (3-month period defined discontinuity with at least 2 months with no/low activity (X)), 1–6 months after discontinuity and 7–12 months after discontinuity and (C) patient outcome assessment (four outcomes) in our four defined periods. ACSC, ambulatory care sensitive conditions; GP, general practitioner; OOH, out-of-hours.